Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

atorvastatin

atorvastatin 40mg, given orally daily for 3 months.

Trial Locations (1)

64111

The Center for Rheumatic Disease, Allergy, and Immunology, Kansas City

All Listed Sponsors
collaborator

Saint Luke's Health System

OTHER

lead

The Center for Rheumatic Disease, Allergy, & Immunology

OTHER

NCT00519363 - Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors | Biotech Hunter | Biotech Hunter